Annual report pursuant to Section 13 and 15(d)

Note 17 ??? Share Based Awards (Tables)

v3.22.2
Note 17 – Share Based Awards (Tables)
12 Months Ended
Apr. 30, 2022
Share-Based Payment Arrangement [Abstract]  
[custom:ScheduleOfAssumptionsUsed1TableTextBlock]
      2022       2021  
Exercise Price   1.692.82     2.013.95  
Stock price on date of grant     1.69 2.82       2.013.95  
Risk-free interest rate     0.471.91%       0.381.66%  
Dividend yield                  
Expected term (years)      3.75 10.00       5.87 10.00  
Volatility      210.68273.46%       88.60 91.44%  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
Options   Shares   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Term   Aggregate Intrinsic Value
                                 
Outstanding as of April 30, 2020     1,597,475     $ 1.10                  
Granted     600,000       3.63                  
Exercised                                  
Forfeited or expired                                  
Outstanding as of April 30, 2021     2,197,475     1.79       8.68        4,943,870   
Granted     1,681,000       2.58                  
Exercised     (150,000     2.49                  
Forfeited or expired     (34,333     2.11                  
Outstanding as of April 30, 2022     3,694,142     2.17       8.56     1,407,545  
Exercisable as of April 30, 2022     2,094,642     $ 1.90       7.91     $ 1,058,620  
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Restricted Stock   Shares   Weighted Average Grant-Date Fair Value Per Share
Unvested and outstanding as of April 30, 2020            $     
Granted     1,000,000       2.69  
Vested     (312,500 )     2.69  
Forfeited                  
Unvested and outstanding as of April 30, 2021     687,500       2.69  
Granted     995,659       2.55  
Vested     (599,484 )     2.64  
Forfeited                  
Unvested and outstanding as of April 30, 2022     1,083,675     $ 2.59  
Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]
    2022   2021
General and administrative   $ 1,521,951     $ 1,688,025  
Research and development     516,456       1,269,987  
Operations     783,781       220,048  
Sales and marketing     469,447       210,156  
 Total   $ 3,291,635     $ 3,388,216